ITU Unit Action

KHAPZORY

ACROTECH BIOPHARMA LLC

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88165625 FILING DATE 10/23/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY GOODWIN, KATRINA JOYE
L.O. ASSIGNED N40-NOT FOUND

PUB INFORMATION

RUN DATE 09/24/2019
PUB DATE 01/15/2019
STATUS 748-STATEMENT OF USE - TO EXAMINER
STATUS DATE 09/23/2019
LITERAL MARK ELEMENT KHAPZORY

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT KHAPZORY
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 21-SUBSEQUENT OWNER AFTER PUBLICATION
NAME ACROTECH BIOPHARMA LLC
ADDRESS 279 PRINCETON HIGHTSTOWN ROAD
EAST WINDSOR, NJ 08520
ENTITY 16-LTD LIAB CO
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 12/10/2018 FIRST USE IN COMMERCE DATE 12/10/2018 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
09/23/2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE 013
08/27/2019 IUAF S USE AMENDMENT FILED 012
09/20/2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 011
08/27/2019 EISU I TEAS STATEMENT OF USE RECEIVED 010
06/05/2019 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP 009
03/12/2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 008
01/15/2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 007
01/15/2019 PUBO A PUBLISHED FOR OPPOSITION 006
12/26/2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 005
12/11/2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 004
12/06/2018 DOCK D ASSIGNED TO EXAMINER 003
11/04/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
10/26/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Louis C. Cullman
CORRESPONDENCE ADDRESS LOUIS C. CULLMAN
K&L GATES LLP
1 PARK PLAZA, 12TH FLOOR
IRVINE, CA 92614
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Spectrum Pharmaceuticals, Inc.
ADDRESS 157 Technology Drive
Irvine, CA 92618
ENTITY 03-CORPORATION
CITIZENSHIP Delaware
PARTY TYPE 10-ORIGINAL APPLICANT
NAME Spectrum Pharmaceuticals, Inc.
ADDRESS 157 Technology Drive
Irvine, CA 92618
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed